$RXST News

RxSight Reports Inducement Grants as Permitted by the Nasdaq Listing Rules

RxSight, Inc. to Report Third Quarter 2026 Financial Results on November 3

RxSight Appoints Eye Care Industry Leaders to Drive Commercial Transformation

RxSight's Utilization-Growth Upside Faces Structural, Competitive Headwinds, BofA Says

B of A Securities Maintains Underperform on RxSight, Lowers Price Target to $5.5

RxSight, Inc. to Participate in the Wells Fargo Healthcare Conference

Could Alcon (ALC) and RxSight (RXST)’s Partnership Reshape the Future of Cataract Surgery?

RxSight (RXST) Q2 2026 Earnings Call Transcript

Stifel Maintains Hold on RxSight, Lowers Price Target to $7

UBS Maintains Neutral on RxSight, Raises Price Target to $6.3

RxSight Inc (RXST) (Q2 2026) Earnings Call Highlights: Strategic Pivot Amid Revenue Decline and ...

RxSight Q2 Earnings Call Highlights

RxSight, Inc. (RXST) Q2 2026 Earnings Call Transcript

RxSight (NASDAQ:RXST) Slips After Q2 Revenue Matches, Loss Narrows

RxSight, Inc. Reports Second Quarter 2026 Results and Provides Update on 2026 Outlook

Earnings Preview: RxSight, Inc. (RXST) Q2 Earnings Expected to Decline

RxSight Reports Inducement Grants as Permitted by the Nasdaq Listing Rules

RxSight (RXST) Surges 6.1%: Is This an Indication of Further Gains?

RxSight Announces Appointments of Aziz Mottiwala as Chief Executive Officer and Ron Kurtz, M.D. as Chief Medical Officer

RxSight Appoints Aziz Mottiwala President, CEO, Effective July 20, Succeeding Ron Kurtz